Download
s00277-021-04513-z.pdf 1,61MB
WeightNameValue
1000 Titel
  • Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique
1000 Autor/in
  1. Owattanapanich, Weerapat |
  2. Herzig, Julia |
  3. Jahn, Nikolaus |
  4. Panina, Ekaterina |
  5. Ruchutrakool, Theera |
  6. Kungwankiattichai, Smith |
  7. Issaragrisil, Surapol |
  8. Döhner, Hartmut |
  9. Döhner, Konstanze |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-10
1000 Erschienen in
1000 Quellenangabe
  • 100(8):1983-1993
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00277-021-04513-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285357/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Several molecular aberrations affect the prognosis of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) with excess blasts (EB). This study aimed to determine the incidence and clinical impact of molecular genetic aberrations in Thai patients with AML and MDS-EB, detected by the next-generation sequencing (NGS) technique. This prospective, observational study was conducted between 2018 and 2020 on newly diagnosed Thai AML or MDS-EB patients aged above 15 years. NGS was performed using a custom amplicon-based targeted enrichment assay for 42 genes recurrently mutated in myeloid neoplasms. The molecular results were correlated with baseline patient and disease characteristics as well as outcomes. Forty-nine patients were enrolled in this study. The median age was 56 years (interquartile range [IQR], 44-64), with nearly equal proportions of males and females. The median number of mutations was 3 (IQR, 2-4). The most frequent alterations were FLT3 internal tandem duplications (ITD) (28.6%), DNMT3A (24.5%), and WT1 (22.4%) mutations. FLT3-ITD was more frequent in the de novo AML group than in the MDS/secondary AML group, whereas in the MDS/secondary AML group, ASXL1, ETV6, and SRSF2 mutations were more frequent. Patients aged greater than 65 years and patients with mutated TP53 were more likely to have inferior overall survival from multivariate analysis. FLT3-ITD was the most common mutation among newly diagnosed Thai AML patients. TP53 mutation and advanced age were independent adverse factors for survival outcome. The genetic landscapes of AML patients vary between national populations. Thai Clinical Trials Registry identifier: TCTR20190227003.
1000 Sacherschließung
lokal Female [MeSH]
lokal Mutation [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Myelodysplastic Syndromes/therapy [MeSH]
lokal Middle Aged [MeSH]
lokal Myelodysplastic Syndromes/genetics [MeSH]
lokal Thailand
lokal Thailand/epidemiology [MeSH]
lokal DNA (Cytosine-5-)-Methyltransferases/genetics [MeSH]
lokal Original Article
lokal Acute myeloid leukemia
lokal Genetic
lokal Male [MeSH]
lokal Leukemia, Myeloid, Acute/epidemiology [MeSH]
lokal Leukemia, Myeloid, Acute/genetics [MeSH]
lokal Myelodysplastic Syndromes/epidemiology [MeSH]
lokal fms-Like Tyrosine Kinase 3/genetics [MeSH]
lokal Next-generation sequencing
lokal Leukemia, Myeloid, Acute/therapy [MeSH]
lokal Molecular
lokal High-Throughput Nucleotide Sequencing [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/T3dhdHRhbmFwYW5pY2gsIFdlZXJhcGF0|https://frl.publisso.de/adhoc/uri/SGVyemlnLCBKdWxpYQ==|https://frl.publisso.de/adhoc/uri/SmFobiwgTmlrb2xhdXM=|https://frl.publisso.de/adhoc/uri/UGFuaW5hLCBFa2F0ZXJpbmE=|https://frl.publisso.de/adhoc/uri/UnVjaHV0cmFrb29sLCBUaGVlcmE=|https://frl.publisso.de/adhoc/uri/S3VuZ3dhbmtpYXR0aWNoYWksIFNtaXRo|https://frl.publisso.de/adhoc/uri/SXNzYXJhZ3Jpc2lsLCBTdXJhcG9s|https://frl.publisso.de/adhoc/uri/RMO2aG5lciwgSGFydG11dA==|https://frl.publisso.de/adhoc/uri/RMO2aG5lciwgS29uc3Rhbnpl
1000 Hinweis
  • DeepGreen-ID: 02f1dc34fc1c42c585bd5832150b364f ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6447821.rdf
1000 Erstellt am 2023-05-03T16:32:05.920+0200
1000 Erstellt von 322
1000 beschreibt frl:6447821
1000 Zuletzt bearbeitet Fri Oct 20 21:22:22 CEST 2023
1000 Objekt bearb. Fri Oct 20 21:22:22 CEST 2023
1000 Vgl. frl:6447821
1000 Oai Id
  1. oai:frl.publisso.de:frl:6447821 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source